DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case–Control Study

INTRODUCTION: The risk of rheumatoid arthritis (RA) associated with dipeptidyl peptidase-4 inhibitor (DPP-4i) use is unclear. This study assesses the RA risk associated with DPP-4i use among a diabetic cohort initiating second-line therapy. METHODS: This was a nested case–control study, using the ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Kathe, Niranjan, Shah, Anuj, Said, Qayyim, Painter, Jacob T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801239/
https://www.ncbi.nlm.nih.gov/pubmed/29236221
http://dx.doi.org/10.1007/s13300-017-0353-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801239/
https://www.ncbi.nlm.nih.gov/pubmed/29236221
http://dx.doi.org/10.1007/s13300-017-0353-5

Ejemplares similares